Top Midday Gainers
NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said.Shares catapulted 200% as intraday trading volume soared to over 101 million from a daily average of about 103,000.Shuttle Pharmaceuticals (SHPH) soared 36% after a regulatory filing showed HRT Financial bought additional shares of the firm.More than 50.1 million shares were traded intraday, compared with a daily average of about 1.1 million.Goldman Sachs' (GS) Q2 results topped analysts' estimates as a record performance in the global banking and markets business propelled revenue growth.Shares jumped 7.6%, with intraday trading volume rising to over 2.3 million from a daily average of about 2.1 million.Price: $1127.05, Change: $+81.14, Percent Change: +7.76%
